NCT06245421 - Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

August 12, 2024

Study Completion Date

September 30, 2024

Conditions

Dry Eye

Interventions

DEVICE

DM934

1 drop in each eye, 4 to 6 times per day

DEVICE

Théalose

1 drop in each eye, 4 to 6 times per day

Trial Locations (5)

Eurofins Dermscan, Aix-en-Provence

Eurofins EVIC, Bordeaux

Eurofins Dermscan Poland, Gdansk

IOBA, Valladolid

Ocular Technology Group, London